|
Video: What is a Stock Split?
|
|
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of therapies addressing unmet medical needs. Co. has two approved products: EGRIFTA SV® in the U.S., and Trogarzo® in the U.S., the European Union and the U.K. EGRIFTA SV® is the therapy in the U.S. for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy. Trogarzo® is the HIV treatment. The treatment is infused every two weeks. It is a class of antiretrovirals, or ARV, and is a long-acting ARV therapy that can lead to an undetectable viral load in combination with other ARVs. According to our Theratechnologies stock split history records, Theratechnologies has had 1 split. | |
|
Theratechnologies (THTX) has 1 split in our Theratechnologies stock split history database. The split for THTX took place on July 31, 2023. This was a 1 for 4 reverse split, meaning for each 4 shares of THTX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.
When a company such as Theratechnologies conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Theratechnologies stock split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Theratechnologies shares, starting with a $10,000 purchase of THTX, presented on a split-history-adjusted basis factoring in the complete Theratechnologies stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/07/2014 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$2.04 |
|
End price/share: |
$1.28 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-37.25% |
|
Average Annual Total Return: |
-4.56% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,271.33 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
07/31/2023 | 1 for 4 |
|
|